The BLLF1 Polyclonal Antibody (PACO34826) is a valuable tool for researchers studying the Epstein-Barr virus (EBV) and its associated proteins. This antibody, generated in rabbits, is highly specific and reacts strongly with human samples, making it ideal for use in various immunoassays and research applications. The BLLF1 protein is a key component of the EBV virus and plays a crucial role in viral replication and immune evasion. By targeting the BLLF1 protein, researchers can gain insights into the mechanisms of EBV infection and potentially develop new strategies for combating EBV-associated diseases, such as lymphomas and nasopharyngeal carcinomas.
With its high specificity and reactivity, the BLLF1 Polyclonal Antibody (PACO34826) is a valuable tool for researchers studying EBV biology and exploring potential therapeutic interventions against EBV-associated malignancies. Its use in Western blot and immunofluorescence assays allows for precise detection and analysis of the BLLF1 protein in various experimental settings.
Antibody Name:
BLLF1 Antibody (PACO34826)
Antibody SKU:
PACO34826
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA
Recommended Dilutions:
Species Reactivity:
Epstein-Barr virus
Immunogen:
Recombinant Epstein-Barr virus Envelope glycoprotein GP350 protein (1-493AA)
Initiates virion attachment to host B-lymphocyte cell, leading to virus entry. Acts by binding to host CR2 at the surface of B-lymphocytes, facilitating the binding of viral glycoprotein gp42 to HLA class II molecules. Attachment triggers virion-host membrane fusion and invasion of the host cell.
Initiates virion attachment to host B-lymphocyte cell, leading to virus entry. Acts by binding to host CR2 at the surface of B-lymphocytes, facilitating the binding of viral glycoprotein gp42 to HLA class II molecules. Attachment triggers virion-host membrane fusion and invasion of the host cell.
